Tamil Nadu, India, November 20, 2024: Global pharma major Lupin Limited (Lupin) and the National Conference of Pulmonary Diseases (NAPCON) 2024 successfully hosted the second ‘A Step Towards HealThy Lungs Walkathon’ on 20th November 2024, at the Racecourse, Coimbatore, Tamil Nadu. This event aimed to raise awareness about the escalating prevalence of chronic respiratory conditions such as Chronic Obstructive Pulmonary Disease (COPD) and emphasize the critical role of regular physical activity and healthy lifestyles for their prevention and management. The Walkathon was flagged off by Mr. Hirak Bose, Senior Vice President, Sales & Marketing, Lupin and Dr. MohanKumar T, Organizing Chairman of NAPCON 2024.

With walk categories of 2.5 km and 5 km, the walkathon witnessed enthusiastic participation from the Indian Medical Association (IMA), Rotary Club, and the community at large, underscoring a unified commitment to promoting respiratory health and advocating for healthier living practices. Certificates of participation were presented to all the attendees.

The event concluded with a renewed commitment for better lung health, symbolizing not just a health milestone, but also a strategic step towards a better society.

Lupin and NAPCON remain steadfast in their commitment to promoting lung health and increasing COPD awareness. This collaborative effort signifies a robust alliance in the healthcare industry, poised to make a substantial impact on public health in India.

Dr. Mohan Kumar T, Organizing Chairman of NAPCON 2024 stated, “The surge in respiratory ailments is a significant public health concern. Through this Walkathon, we aspire to inspire individuals to embrace healthier lifestyles and highlight the importance of physical activity in maintaining optimal lung health.”

Echoing this sentiment, Dr. Karthikeyan R., Organizing Secretary of NAPCON 2024 added, “Environmental pollution is a major contributor to respiratory diseases. Our Walkathon not only promotes physical fitness but also serves as a call to action for cleaner air and a healthier environment.”

Rajeev Sibal, President, India Region Formulations, Lupin said, ” The rising incidence of respiratory illnesses such as COPD, is affecting public health. We at Lupin aim to raise awareness about Chronic Obstructive Pulmonary Disease and support and inspire those affected by this challenging condition. This Walkathon reaffirms our commitment to fostering healthier communities.”

Hirak Bose, Senior Vice President, Sales & Marketing, Lupin said, “This COPD Walkathon is a progressive step towards Healthy Lungs and marks a significant milestone in our journey to promote lung health. Supporting initiatives such as this Walkathon aligns with our mission to enhance patient well-being and promote awareness about the benefits of an active lifestyle.”

About Lupin
Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 22,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.
To know more, visit www.lupin.com or follow us on LinkedIn https://www.linkedin.com/company/lupin

For further information or queries please contact –

Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications, Lupin
rajalakshmiazariah@lupin.com